Hims & Hers Health (NYSE:HIMS) Trading Up 4%

Shares of Hims & Hers Health, Inc. (NYSE:HIMS) were up 4% during mid-day trading on Monday . The company traded as high as $21.14 and last traded at $20.99. Approximately 3,239,400 shares were traded during mid-day trading, a decline of 57% from the average daily volume of 7,469,176 shares. The stock had previously closed at $20.19.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on HIMS shares. Piper Sandler raised their price objective on shares of Hims & Hers Health from $11.00 to $13.00 and gave the company a “neutral” rating in a research note on Tuesday, May 7th. Canaccord Genuity Group raised their price objective on shares of Hims & Hers Health from $20.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, May 22nd. Citigroup cut shares of Hims & Hers Health from a “buy” rating to a “neutral” rating and raised their price objective for the company from $16.00 to $20.00 in a research note on Wednesday, May 22nd. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Hims & Hers Health from $14.00 to $16.00 and gave the stock a “hold” rating in a research report on Tuesday, May 7th. Finally, Bank of America lifted their price target on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock a “buy” rating in a research report on Thursday, June 13th. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $17.00.

Hims & Hers Health Stock Up 4.0 %

The business’s fifty day moving average is $17.59 and its 200 day moving average is $13.55. The firm has a market capitalization of $4.51 billion, a price-to-earnings ratio of -2,099.00 and a beta of 1.08.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings data on Monday, May 6th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. Hims & Hers Health had a negative net margin of 0.24% and a negative return on equity of 0.70%. The business had revenue of $278.20 million for the quarter, compared to analyst estimates of $270.37 million. During the same period last year, the business posted ($0.05) earnings per share. The firm’s quarterly revenue was up 45.8% on a year-over-year basis. Equities research analysts expect that Hims & Hers Health, Inc. will post 0.2 EPS for the current year.

Insider Buying and Selling at Hims & Hers Health

In other Hims & Hers Health news, CEO Andrew Dudum sold 188,888 shares of Hims & Hers Health stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $14.97, for a total value of $2,827,653.36. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, COO Melissa Baird sold 11,751 shares of the business’s stock in a transaction dated Friday, April 5th. The shares were sold at an average price of $14.58, for a total transaction of $171,329.58. Following the transaction, the chief operating officer now directly owns 538,932 shares in the company, valued at approximately $7,857,628.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Andrew Dudum sold 188,888 shares of the business’s stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $14.97, for a total transaction of $2,827,653.36. The disclosure for this sale can be found here. In the last three months, insiders have sold 960,288 shares of company stock worth $16,891,553. Insiders own 17.71% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. increased its stake in shares of Hims & Hers Health by 23.0% during the 4th quarter. Victory Capital Management Inc. now owns 18,348 shares of the company’s stock worth $163,000 after purchasing an additional 3,429 shares during the last quarter. Graham Capital Management L.P. boosted its holdings in shares of Hims & Hers Health by 39.4% during the 3rd quarter. Graham Capital Management L.P. now owns 340,338 shares of the company’s stock worth $2,141,000 after buying an additional 96,277 shares during the period. Forerunner Ventures Management LLC bought a new stake in shares of Hims & Hers Health during the 4th quarter worth about $86,836,000. Vanguard Group Inc. boosted its holdings in shares of Hims & Hers Health by 3.1% during the 3rd quarter. Vanguard Group Inc. now owns 14,126,744 shares of the company’s stock worth $88,857,000 after buying an additional 428,671 shares during the period. Finally, Bridgefront Capital LLC boosted its holdings in shares of Hims & Hers Health by 176.3% during the 4th quarter. Bridgefront Capital LLC now owns 39,622 shares of the company’s stock worth $353,000 after buying an additional 25,284 shares during the period. 63.52% of the stock is currently owned by institutional investors and hedge funds.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.